FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Eli Lilly & Trulicity Recall

Trulicity (dulaglutide), 0

Eli Lilly & Company · Indianapolis, IN

Risk level
Class II
Reported by FDA
Sep 1, 2021
Recall ID
D-0773-2021
Check your lot numberHow we source this data

Summary

Eli Lilly & recalled Trulicity starting Aug 19, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0773-2021 on Sep 1, 2021. Reason: Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product. Status: Terminated.

Why it was recalled

Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product.

Product description

Trulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80

Lot numbers, UPCs & expiration codes

Lot number: D396436C

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0773-2021
Classification
Class II
Status
Terminated
Recall initiated
Aug 19, 2021
FDA report date
Sep 1, 2021
Quantity
119,539 4-packs
Recall type
Voluntary: Firm initiated
Recalling firm
Eli Lilly & Company

Original FDA data

Every field from FDA enforcement report D-0773-2021, exactly as published.

Show all FDA fields
City
Indianapolis
State
IN
Status
Terminated
Country
United States
Event ID
88505
Address
839 S Delaware St
Code information
Lot number: D396436C
Postal code
46225-1782
Report date
Sep 1, 2021
Product type
Drugs
Recall number
D-0773-2021
Classification
Class II
Recalling firm
Eli Lilly & Company
Product quantity
119,539 4-packs
Termination date
Aug 7, 2023
Reason for recall
Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Trulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80
Distribution pattern
USA Nationwide
Recall initiation date
Aug 19, 2021
Initial firm notification
Letter
Center classification date
Aug 26, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0773-2021, published Sep 1, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls